Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Furosemide
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Gerresheimer: FDA grants Tentative Approval of SQ Innovation's Lasix® ONYU*
Details : Lasix ONYU (furosemide subcutaneous infusion) works by inhibiting electrolyte reabsorption, is indicated for the treatment of fluid overload in adult patients with congestive heart failure.
Product Name : Lasix ONYU
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 16, 2024
Lead Product(s) : Furosemide
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
